This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Modernatx, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Lori Panther: Innovator in mRNA Vaccine Development
Introduction
Lori Panther is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of vaccine development, particularly in the area of mRNA technology. Her work focuses on creating innovative solutions to combat viral infections.
Latest Patents
Lori Panther holds a patent for an HMPV/hPIV3 mRNA vaccine composition. This patent describes a vaccine composition that comprises a chemically-modified messenger ribonucleic acid (mRNA) encoding a hMPV fusion (F) glycoprotein and a chemically-modified mRNA encoding a hPIV3 F glycoprotein. The formulation is designed in a cationic lipid nanoparticle formulation, which is crucial for inducing an antigen-specific immune response.
Career Highlights
Lori Panther is currently associated with Moderna, Inc., a leading biotechnology company known for its pioneering work in mRNA technology. Her role at Moderna has allowed her to be at the forefront of vaccine innovation, contributing to the development of cutting-edge therapies.
Collaborations
Throughout her career, Lori has collaborated with notable colleagues, including Christine Shaw and Igor Smolenov. These collaborations have enhanced her research and development efforts, leading to advancements in vaccine technology.
Conclusion
Lori Panther is a key figure in the field of mRNA vaccine development, with her innovative work paving the way for future advancements in immunization. Her contributions are vital in the ongoing fight against viral diseases.